10x Genomics (TXG) Tops Q2 EPS by 16c
Get Alerts TXG Hot Sheet
Join SI Premium – FREE
10x Genomics (NASDAQ: TXG) reported Q2 EPS of ($0.10), $0.16 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $115.8 million versus the consensus estimate of $112.85 million.
GUIDANCE:
10x Genomics sees FY2021 revenue of $480-500 million.
For earnings history and earnings-related data on 10x Genomics (TXG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rexford Industrial Realty (REXR) Reports In-Line Q1 EPS, provides guidance
- Liberty Oilfield Services (LBRT) Misses Q1 EPS by 6c, provides outlook
- Discover Financial Services (DFS) Reports Q1 EPS of $1.10
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!